PAI Pharma

简介

总部: US

PAI Pharma 的结构

公司

4 个关联

归属投资与持股

自有产品与技术

关系出现时间2026

PAI Pharma公司 · 4 个关联

第 1 层

归属投资与持股2

自有产品与技术2

在关系网络中的位置

第 3930 位，共 104260 个前 4%

4 条直接关系

所在群组共 5 个紧密关联的对象，核心是

Sterile and ready-to-use pharmaceutical products Olympus Partners Oral liquid medicines Nexus Pharmaceuticals, LLC

本周新增关系

制造 Sterile and ready-to-use pharmaceutical products
属于 Olympus Partners
制造 Oral liquid medicines
收购 Nexus Pharmaceuticals, LLC

按有证据的公开关系计算，每天更新。

它和……是怎么连起来的

关系

公司之间的资金

谁投资、持有、收购或为谁融资，来自 AiSeek 有证据的关系。

从PAI Pharma流出

Nexus Pharmaceuticals, LLC收购

线只表示这条关系存在以及方向，粗细不代表金额；圆点移动只是为了指示方向。

箭头表示关系方向，可按业务类别筛选。

PAI Pharma收购 →Nexus Pharmaceuticals, LLC
公司 · Nexus Pharmaceuticals, LLC证据 1
事实90%
查看证据
- 公司披露PR Newswire news releases2026-11-13 02:00
  PAI Pharma ("PAI"), a portfolio company of Olympus Partners, and a leading U.S. developer, manufacturer, and marketer of oral liquid medicines, and Ready-To-Use ("RTU") sterile injectable and hospital-focused products, today announced the acquisition of Nexus Pharmaceuticals, LL…
  查看来源
PAI Pharma属于 →Olympus Partners
公司 · Olympus Partners证据 1
事实90%
查看证据
- 公司披露PR Newswire news releases2026-11-13 02:00
  PAI Pharma, a portfolio company of Olympus Partners.
  查看来源
PAI Pharma制造 →Oral liquid medicines
产品 · Oral liquid medicines证据 1
事实90%
查看证据
- 公司披露PR Newswire news releases2026-11-13 02:00
  PAI Pharma, headquartered in Parsippany, NJ, is a leading U.S. pharmaceutical company specializing in the development, manufacturing, and marketing of high-quality oral liquid, sterile and ready-to-use pharmaceutical products.
  查看来源
PAI Pharma制造 →Sterile and ready-to-use pharmaceutical products
产品 · Sterile and ready-to-use pharmaceutical products证据 1
事实90%
查看证据
- 公司披露PR Newswire news releases2026-11-13 02:00
  PAI Pharma, headquartered in Parsippany, NJ, is a leading U.S. pharmaceutical company specializing in the development, manufacturing, and marketing of high-quality oral liquid, sterile and ready-to-use pharmaceutical products.
  查看来源

显示第 1 至 4 条，共 4 条

结论

结合来源阅读结论，展开条目查看证据。

事实证据 1

收购Nexus Pharmaceuticals, LLC

PAI Pharma ("PAI"), a portfolio company of Olympus Partners, and a leading U.S. developer, manufacturer, and marketer of oral liquid medicines, and Ready-To-Use ("RTU") sterile injectable and hospital-focused products, today announced the acquisition of Nexus Pharmaceuticals, LL…

PR Newswire news releases · 2026-11-13 02:00

查看证据

公司披露PR Newswire news releases2026-11-13 02:00
PAI Pharma ("PAI"), a portfolio company of Olympus Partners, and a leading U.S. developer, manufacturer, and marketer of oral liquid medicines, and Ready-To-Use ("RTU") sterile injectable and hospital-focused products, today announced the acquisition of Nexus Pharmaceuticals, LL…
查看来源

事实证据 1

属于Olympus Partners

PAI Pharma, a portfolio company of Olympus Partners.

PR Newswire news releases · 2026-11-13 02:00

查看证据

公司披露PR Newswire news releases2026-11-13 02:00
PAI Pharma, a portfolio company of Olympus Partners.
查看来源

事实证据 1

制造Oral liquid medicines

PAI Pharma, headquartered in Parsippany, NJ, is a leading U.S. pharmaceutical company specializing in the development, manufacturing, and marketing of high-quality oral liquid, sterile and ready-to-use pharmaceutical products.

PR Newswire news releases · 2026-11-13 02:00

查看证据

公司披露PR Newswire news releases2026-11-13 02:00
PAI Pharma, headquartered in Parsippany, NJ, is a leading U.S. pharmaceutical company specializing in the development, manufacturing, and marketing of high-quality oral liquid, sterile and ready-to-use pharmaceutical products.
查看来源

事实证据 1

制造Sterile and ready-to-use pharmaceutical products

PAI Pharma, headquartered in Parsippany, NJ, is a leading U.S. pharmaceutical company specializing in the development, manufacturing, and marketing of high-quality oral liquid, sterile and ready-to-use pharmaceutical products.

PR Newswire news releases · 2026-11-13 02:00

查看证据

公司披露PR Newswire news releases2026-11-13 02:00
PAI Pharma, headquartered in Parsippany, NJ, is a leading U.S. pharmaceutical company specializing in the development, manufacturing, and marketing of high-quality oral liquid, sterile and ready-to-use pharmaceutical products.
查看来源

显示第 1 至 4 条，共 4 条

市场与估值

估值数据需要 Pro 或 Research。

升级到 Pro 解锁

简介

PAI Pharma 的结构

PAI Pharma

归属投资与持股2

自有产品与技术2

在关系网络中的位置

关系

公司之间的资金

从PAI Pharma流出

结论

市场与估值

推荐一个值得监测的页面